Reported Dec 21, 2022 · Announced
Lupin Pharmaceuticals Inc. recalls Lupin Quinapril 20 and 40 mg tablets due to Presence of nitrosamine impurity, N-Nitroso-Quinapril
Lupin Pharmaceuticals Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Quinapril 20 and 40 mg tablets BrandLupin. Drugs
Why it was recalled
Presence of nitrosamine impurity, N-Nitroso-Quinapril
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.